| CTRI Number |
CTRI/2026/01/100150 [Registered on: 01/01/2026] Trial Registered Prospectively |
| Last Modified On: |
24/12/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Comparative study between rubber band ligation and laser hemorrhoidoplasty in patient presenting with hemorrhoids for resolution of symptoms associated with hemorrhoids (grade II and III) |
|
Scientific Title of Study
|
Rubber Band Ligation Versus Laser Haemorrhoidoplasty : A Randomised Controlled Trial |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| AIIMSA3257/27.02.2025 |
Protocol Number |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Nalamwad Durgeshwari Balaji |
| Designation |
Junior Resident |
| Affiliation |
AIIMS New Delhi |
| Address |
Dept. of Surgical Disciplines AIIMS New Delhi Ansari Nagar
South DELHI 110029 India |
| Phone |
7020643572 |
| Fax |
|
| Email |
durgeshwari0210@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Uttam Kumar Thakur |
| Designation |
Assistant Professor |
| Affiliation |
AIIMS New Delhi |
| Address |
Dept. of Surgical Disciplines AIIMS New Delhi Ansari Nagar
South DELHI 110029 India |
| Phone |
7087009909 |
| Fax |
|
| Email |
ukt005@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Uttam Kumar Thakur |
| Designation |
Assistant Professor |
| Affiliation |
AIIMS New Delhi |
| Address |
Dept. of Surgical Disciplines AIIMS New Delhi Ansari Nagar
South DELHI 110029 India |
| Phone |
7087009909 |
| Fax |
|
| Email |
ukt005@gmail.com |
|
|
Source of Monetary or Material Support
|
| Dept of Surgical Disciplines, AIIMS New Delhi, Ansari Nagar, Delhi. 110029 |
|
|
Primary Sponsor
|
| Name |
Dept of Surgical Disciplines |
| Address |
AIIMS New Delhi, Ansari Nagar, Delhi. 110029 |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Nalamwad Durgeshwari |
AIIMS New Delhi |
Room no 415, fourth floor, Dept. of Surgical Disciplines South DELHI |
7020643572
durgeshwari0210@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Intitute Ethics Committee, All India Institute of Medical sciences, New Delhi |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: K641||Second degree hemorrhoids, (2) ICD-10 Condition: K642||Third degree hemorrhoids, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Laser Hemorrhoidoplasty |
Laser application to grade II and III haemorrhoids using laser fibre |
| Intervention |
Rubber band ligation |
Rubber band ligation of grade II and III haemorrhoids using rubber band applicator |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
Inclusion criteria
1. Adult patients aged 18 to 70 years
2. Grade II and III internal haemorrhoids
|
|
| ExclusionCriteria |
| Details |
Exclusion criteria
1. Circumferential haemorrhoids or haemorrhoids in all 3, 7 and 11 o’ clock positions
2. Patients on anticoagulant and antiplatelet agents
3. Patients developing haemorrhoids secondary to portal hypertension
4. Patients who have undergone previous procedure for haemorrhoids
5. Presence of other associated perianal pathology including anal stenosis, anal fissure, fistula or anorectal tumors.
6. Patients on opioids or any substance abuse
7. Immunocompromised patients - Known HIV/ AIDS, patients on immunosuppressive drugs including steroids
8. Previous surgical anastomosis less than 3 cm from dentate line
9. Patients with inflammatory bowel disease
10. Fecal incontinence
11. Obstructed defecation syndrome
12. Irritable bowel syndrome with severe constipation or diarrhoea symptoms
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
|
|
Primary Outcome
|
| Outcome |
TimePoints |
Resolution of symptoms (rectal bleeding, discomfort, itching, mucous discharge), determined by direct or telephonic interview of patients at three months after RBL or LH
|
24 hours, 1 week, 2 weeks, 3 months |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1. Incidence of pain at 24 hours, 1 week, 2 weeks and 3 months, measured by Numerical Pain Rating Scale, on a scale of 0 to 10, where 0 is no pain and 10 is maximum possible pain
2. Procedure time, measured in minutes
3. Incidence of post procedure complications - Oedema, abscess, urinary retention, anal ulcer, acute thrombosis, unplanned hospital visits, hospital admissions at 30 days
4. Incidence of downgrading rates of hemorrhoidal disease by 1 grade or more, determined by direct examination by a trained surgeon during 3-montyh follow up visit.
|
24 hours, 1 week, 2 weeks, 3 months |
|
|
Target Sample Size
|
Total Sample Size="64" Sample Size from India="64"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
07/12/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Clinical Study Report
- Who will be able to view these files?
Response - Anyone
- For what types of analyses will this data be available?
Response - To achieve aims in the approved proposal.
- By what mechanism will data be made available?
Response - Proposals should be directed to [durgeshwari0210@gmail.com].
- For how long will this data be available start date provided 31-12-2025 and end date provided 31-07-2027?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - nil
|
|
Brief Summary
|
Internal hemorrhoids are dilated vascular cushions above the dentate line. Internal hemorrhoids can lead to a clinical spectrum of symptoms ranging from bleeding PR, perianal discomfort and itching, constipation, and many more. Currently, a number of treatment modalities exist for the treatment including conservative management, rubber band ligation, open surgeries, etc., with the current gold standard being rubber band ligation for grade 1 to 3 internal hemorrhoids. In this study, we aim to compare the current gold standard with the newer modality that is laser hemorrhoidoplasty for grade 2 and grade 3 hemorrhoids. It uses laser fiber of argon laser fiber of wavelength 1470 nanometer. Preoperatively, the patient is examined to locate the hemorrhoids and intraoperatively laser pulses are given which results in reduced vascular flow and fibrosis in the long term, thus reducing the size of the pile mass and causing symptomatic relief. |